منابع مشابه
Sulthiame in Treatment of Epilepsy.
of the Health Office and of the Inalende Maternity Centre for all the valuable assistance they afforded us during these trials. We would also like to thank members of the University of Ibadan Health Service, the Abadina Village Council, the health visitors of the School of Nursing, the Department of Social and Preventive Medicine, and the Department of Paediatrics, University of Ibadan, for the...
متن کاملLAMOTRIGINE AS ADD-ON THERAPY IN CHILDREN WITH DRUG-RESISTANT EPILEPSY (IRANIAN EXPERIENCE)
Lamotrigine (LTG), a newly developed antiepileptic drug (AED), is efficacious in treating refractory epilepsy. This study was designed to evaluate the efficacy and safety of LTG as add-on therapy in 40 children with refractory epilepsy. The trial was an open-labeled prospective study in children with drug-resistant epilepsy aged
متن کاملThe clinical efficacy and safety of levetiracetam add-on therapy for child refractory epilepsy.
OBJECTIVE To investigate the clinical efficacy and safety of Levetiracetam (LEV) add-on therapy for child refractory epilepsy. PATIENTS AND METHODS Levetiracetam add-on therapy was tested on 65 children who suffered refractory epilepsy, and clinical seizures. Electroencephalogram (EGG) changes and adverse reactions were observed in these children respectively in three, six and twelve months a...
متن کاملthe efficacy and safety of oxcarbazepine as add-on therapy in intractable epilepsy in children
objective 1-3% of the population suffer from epilepsy. up to 30% of them develop refractory epilepsy and their seizures occur more than once per month despite receiving at least 2 first line antiepileptic drugs. in this group, more efficacious antiepileptics are needed. this study was undertaken to evaluate the efficacy and safety of oxcarbazepine as an adjunction therapy in children with refr...
متن کاملTiagabine add-on for drug-resistant partial epilepsy.
BACKGROUND Epilepsy is a common neurological condition that affects almost 0.5% to 1% of the population. Nearly 30% of people with epilepsy are resistant to currently available drugs. Tiagabine is one of the newer antiepileptic drugs; its effects as an adjunct (add-on) to standard drugs are assessed in this review. OBJECTIVES To evaluate the effects of add-on treatment with tiagabine on seizu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2019
ISSN: 1465-1858
DOI: 10.1002/14651858.cd009472.pub4